What is the recommended dose of Cefpodoxime for a 12-year-old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefpodoxime Dosing for a 12-Year-Old Patient

For a 12-year-old patient, administer cefpodoxime 200 mg orally every 12 hours with food, as this patient falls into the adult/adolescent dosing category (≥12 years of age). 1

Standard Dosing Framework

  • The FDA-approved dosing for adolescents 12 years and older is 200 mg every 12 hours (total daily dose 400 mg) for most respiratory tract infections including pharyngitis, tonsillitis, acute bacterial exacerbations of chronic bronchitis, and acute maxillary sinusitis. 1

  • For community-acquired pneumonia specifically, the dose remains 200 mg every 12 hours but extends to 14 days duration rather than the typical 5-10 days used for upper respiratory infections. 1

  • Cefpodoxime must be administered with food to enhance absorption, as bioavailability is 50% and significantly improved when taken with meals. 1, 2

Indication-Specific Dosing

Respiratory Tract Infections:

  • Pharyngitis/tonsillitis: 200 mg every 12 hours for 5-10 days 1
  • Acute maxillary sinusitis: 200 mg every 12 hours for 10 days 1
  • Community-acquired pneumonia: 200 mg every 12 hours for 14 days 1
  • Acute bacterial exacerbations of chronic bronchitis: 200 mg every 12 hours for 10 days 1

Other Infections:

  • Skin and skin structure infections: 400 mg every 12 hours for 7-14 days 1
  • Uncomplicated urinary tract infection: 100 mg every 12 hours for 7 days 1

Clinical Context and Positioning

  • Cefpodoxime serves as an alternative third-generation cephalosporin when first-line agents like high-dose amoxicillin cannot be used, particularly for β-lactamase-producing Haemophilus influenzae in community-acquired pneumonia. 3, 4

  • The drug demonstrates excellent activity against common pediatric pathogens including penicillinase-producing staphylococci, streptococci, H. influenzae, E. coli, Klebsiella, and Moraxella. 5

  • In clinical trials, cefpodoxime 8-10 mg/kg/day (which translates to approximately 200 mg twice daily for a typical 12-year-old) demonstrated equivalent efficacy to amoxicillin/clavulanic acid, cefixime, and cefuroxime axetil for acute otitis media and respiratory infections. 6

Important Administration Considerations

  • Always administer with food to maximize absorption; antacids or H2-receptor antagonists reduce absorption and should be avoided within 2-3 hours of dosing. 1, 2

  • Peak plasma concentrations occur 1.9-3.1 hours after administration, with a half-life of 1.9-2.8 hours, supporting twice-daily dosing. 2

  • For patients with severe renal impairment (creatinine clearance <30 mL/min), extend dosing interval to every 24 hours. 1

  • No dose adjustment is necessary for patients with hepatic cirrhosis. 1

Common Pitfalls to Avoid

  • Do not use pediatric weight-based dosing (8-10 mg/kg/day) for a 12-year-old—this patient qualifies for adult/adolescent fixed dosing of 200 mg every 12 hours. 1

  • Avoid prescribing cefpodoxime without food instructions, as fasted administration significantly reduces bioavailability. 1, 7

  • Do not prescribe cefpodoxime as first-line therapy for community-acquired pneumonia when high-dose amoxicillin (90 mg/kg/day) is appropriate, as amoxicillin provides superior coverage for penicillin-resistant Streptococcus pneumoniae. 3

References

Guideline

Amoxicillin Dosing for Community-Acquired Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cefdinir Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cefpodoxime: pharmacokinetics and therapeutic uses.

Indian journal of pediatrics, 2003

Research

Cefpodoxime pharmacokinetics in children: effect of food.

The Pediatric infectious disease journal, 1998

Related Questions

What is the recommended dosage of cefpodoxime (Cefpodoxime proxetil) for various infections?
What is the recommended pediatric dose of Cefpodoxime (Cefpodoxime proxetil)?
What is the recommended dosage and treatment guidelines for cefdopoxime (Cefdinir)?
How does aluminium oxide interact with cefpodoxime (antibiotic) absorption?
What is the recommended dosage of Cefpodoxime (Cefpodoxime proxetil) for children?
What are the effects of screen time on the visual acuity of children as young as 2 years old?
What is the treatment for Henoch-Schönlein Purpura (HSP) vasculitis?
When should rifampicin be started in a diabetic patient with acute osteomyelitis caused by Staphylococcus haemolyticus and Klebsiella pneumoniae, who is being treated with ciprofloxacin (fluoroquinolone)?
What are the signs of a basilar skull fracture in an infant?
What is the best course of treatment for a diabetic patient with suspected diabetic ketoacidosis (DKA) and radiological findings suggestive of very early appendicitis, including a dilated appendix, mild mucosal hyperenhancement, and minimal surrounding fat stranding?
What is the role of various receptors, such as serotonin, dopamine, and GABA (Gamma-Aminobutyric Acid), in psychopharmacology and which medications, including Selective Serotonin Reuptake Inhibitors (SSRIs) like fluoxetine (Prozac) and sertraline (Zoloft), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) like venlafaxine (Effexor) and duloxetine (Cymbalta), and atypical antipsychotics like quetiapine (Seroquel) and aripiprazole (Abilify), affect these receptors in the treatment of depression and anxiety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.